Oculis Holding AG (OCS)
NASDAQ: OCS · Real-Time Price · USD
9.27
-0.14 (-1.49%)
At close: Sep 25, 2026, 4:00 PM EDT
9.25
-0.02 (-0.22%)
After-hours: Sep 25, 2026, 7:30 PM EDT
Oculis Holding AG Market Cap
Oculis Holding AG has a market cap or net worth of $572.26 million as of September 25, 2026. Its market cap has decreased by -38.29% in one year.
Market Cap
572.26M
Enterprise Value
292.82M
1-Year Change
-38.29%
Ranking
Category
Stock Price
$9.27
ChartMarket Cap Chart
Since May 18, 2021, Oculis Holding AG's market cap has increased from $159.07M to $572.26M, an increase of 259.76%. That is a compound annual growth rate of 26.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 572.26M | -50.43% |
| Dec 31, 2025 | 1.15B | 61.89% |
| Dec 31, 2024 | 713.06M | 73.50% |
| Dec 29, 2023 | 411.00M | 148.15% |
| Dec 30, 2022 | 165.63M | 4.23% |
| Dec 28, 2021 | 158.90M | -0.10% |
| May 18, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Crescent Biopharma | 609.49M |
| CorMedix | 605.63M |
| CytomX Therapeutics | 599.22M |
| MapLight Therapeutics | 597.99M |
| Monopar Therapeutics | 596.31M |
| Altimmune | 591.33M |
| Allogene Therapeutics | 576.97M |
| Valneva SE | 576.10M |